Dejan Micić

Clostridium difficile Ribotype Does Not Predict Severe Infection

Seth T. Walk, Dejan Micić, Ruchika Jain et al. · Clinical Infectious Diseases · 2012 · 185 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases

Joana Torres, Flavio Caprioli, Triana Lobatón et al. · Journal of Crohn s and Colitis · 2016 · 151 citations · Full text

Medicine, Internal Medicine, Early Detection +16

<i>Clostridium difficile</i>Ribotype 027: Relationship to Age, Detectability of Toxins A or B in Stool With Rapid Testing, Severe Infection, and Mortality

Krishna Rao, Dejan Micić, Mukil Natarajan et al. · Clinical Infectious Diseases · 2015 · 133 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17

Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease

Britt Christensen, Peter R. Gibson, Dejan Micić et al. · Clinical Gastroenterology and Hepatology · 2018 · 90 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

Britt Christensen, Dejan Micić, Peter G. Gibson et al. · Alimentary Pharmacology & Therapeutics · 2018 · 85 citations · Full text

Medicine, Biochemistry, Pharmacotherapy +15